KR100826446B1 - Hericium erinaceus mycelium comprising rice bran and ginseng steamed red and it's cultivation method - Google Patents
Hericium erinaceus mycelium comprising rice bran and ginseng steamed red and it's cultivation method Download PDFInfo
- Publication number
- KR100826446B1 KR100826446B1 KR1020060115795A KR20060115795A KR100826446B1 KR 100826446 B1 KR100826446 B1 KR 100826446B1 KR 1020060115795 A KR1020060115795 A KR 1020060115795A KR 20060115795 A KR20060115795 A KR 20060115795A KR 100826446 B1 KR100826446 B1 KR 100826446B1
- Authority
- KR
- South Korea
- Prior art keywords
- culture
- rice bran
- red ginseng
- mycelium
- functional
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01G—HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
- A01G18/00—Cultivation of mushrooms
- A01G18/10—Mycorrhiza; Mycorrhizal associations
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01G—HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
- A01G18/00—Cultivation of mushrooms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H15/00—Fungi; Lichens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Environmental Sciences (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Neurology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Developmental Biology & Embryology (AREA)
- Medicines Containing Plant Substances (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
도 1은 본 발명의 일실시예에 따른 미강 또는 홍삼을 기질로 한 노루궁뎅이버섯의 기능성 균사체 생산 방법의 흐름도1 is a flow chart of a method for producing functional mycelium of roe deer fungus with substrate of rice bran or red ginseng according to one embodiment of the present invention.
본 발명은 미강 또는 홍삼을 기질로 한 노루궁뎅이버섯의 기능성 균사체 생산 방법 및 이를 이용하여 생산된 미강 또는 홍삼의 유효성분을 함유한 노루궁뎅이버섯의 기능성 균사체에 관한 것으로서, 보다 상세하게는 노루궁뎅이버섯의 기능성 균사체를 대량생산할 뿐만 아니라 미강 또는 홍삼의 유효성분을 함유하게 함으로서, 저렴한 비용으로 노인성 질병, 암, 면역체계 붕괴의 치료 및 뇌기능 활성 등의 효과를 가지는 우수한 품질의 노루궁뎅이버섯의 기능성 균사체를 대량생산 할 수 있도록 한 미강 또는 홍삼을 기질로 한 노루궁뎅이버섯의 기능성 균사체 생산 방법 및 이를 이용하여 생산된 미강 또는 홍삼의 유효성분을 함유한 노루궁뎅이버섯의 기능성 균사체에 관한 것이다.The present invention relates to a method for producing a functional mycelium of roe deer fungus with a base of rice bran or red ginseng, and to a functional mycelium of roe deer fungus containing the active ingredient of rice bran or red ginseng produced using the same, and more specifically, By mass production of functional mycelium, it contains an active ingredient of rice bran or red ginseng, and it is a low-cost functional mycelium of roe deer fungus which has the effect of treating senile disease, cancer, immune system breakdown and brain function activity. The present invention relates to a method for producing a functional mycelium of roe deer fungus with a substrate of rice bran or red ginseng, which enables mass production, and a functional mycelium of roe deer fungus containing an active ingredient of rice bran or red ginseng produced using the same.
일반적으로 노루궁뎅이 버섯(Heiricum erinaceus)은 담자균류, 민주름버섯목, 턱수염버섯과, 산호침버섯속으로 분류되는 버섯으로 그 우수한 기능적 효능으로 인해 산업적으로 많은 관심을 가지고 있는 기능성 버섯 중의 하나이다.In general, Hepicum erinaceus is classified as basidiomycetes, Democratic mushrooms, Beard mushrooms, and Coral Sedimentary Mushrooms, and is one of the functional mushrooms of industrial interest due to its excellent functional efficacy.
주요 약리 활성 성분으로 신경성장인자 합성 유도축진 물질(NGF stimulator)을 비롯해, Hela cell 증식억제, 면역기능 조절 성분, 항암, 식이섬유(베타글루칸) 등이 있다. 특히 자실체 유래의 hericenone류는 천연물로는 아드레날린과 비슷한 정도의 활성을 나타내는 최초의 물질로 알려져 있으며 그 외 erinacine 또한 현재까지 알려진 물질 중에서 그 활성이 가장 강력한 것으로 알려져 있다.Major pharmacologically active ingredients include NGF stimulators, nerve growth factor synthesis inhibitors, Hela cell proliferation inhibitors, immune function modulators, anticancer and dietary fiber (betaglucan). Especially, hericenone derived from fruiting body is known as the first substance that shows similar activity as adrenaline in natural products, and erinacine is also known to have the strongest activity.
1990년 아시안게임때는 중국 선수들의 활력을 증강시키는 원동력이 된 스포츠 드링크 하우타우(Houtou)는 노루궁뎅이버섯(Hericium erinaceus)에 의한 것임은 잘 알려져 있는 사실이다.It is well known that the sports drink Houtou, which became the driving force of the Chinese players during the 1990 Asian Games, was due to Hericium erinaceus.
또한, 노루궁뎅이버섯(Hericium erinaceus)은 우리나라를 비롯한 중국, 일본 등 북반구 온대이북에 널리 분포하는 식용 버섯으로 이 버섯은 참나무, 밤나무 등 활엽수에 기생하는 백색 부후균의 일종이며, 가을철에 많이 발생하는데, Liu에 의해 재배기술이 개발되어 인공재배도 가능해졌다(Liu. C.Y. 1981. Technique of cultivation of monkeyhead mushroom. Edible Fungi, No. 4, 33). 일본에서는 할목 재배나 PE(polyethylene)병을 이용한 균상재배 방법 등 인공재배법이 확립되어 연중 시장에 출하되고 있는 실정이며, 우리나라에서도 최근 인공재배가 시작된 버섯 이다[Ko. H.K. 1998. Cultural characteristics of Hericium erinaceum. M.S. thesis, Korea Univ.]In addition, the roe deer mushroom (Hericium erinaceus) is an edible mushroom widely distributed in the northern temperate hemisphere such as China, Japan, Korea, etc. This mushroom is a kind of white fungi parasitic on hardwoods such as oak and chestnut. Cultivation techniques were developed by Liu, which allowed artificial cultivation (Liu. CY 1981. Technique of cultivation of monkeyhead mushroom. Edible Fungi, No. 4, 33). In Japan, artificial cultivation methods have been established, such as cultivation of hazelnuts and fungal cultivation methods using polyethylene (PE) bottles, and are being shipped to the market all year round. In Korea, artificial cultivation has recently begun. H.K. 1998. Cultural characteristics of Hericium erinaceum. M.S. thesis, Korea Univ.]
노루궁뎅이버섯의 화학성분은 당질과 단백질을 주성분으로 하고, 미네랄을 함유하나 지방함량은 적다(Eisenhut, R., Fritz, D. and Tiefel, P. 1995. Investigations on nutritionally valuable constituents of Hericium erinaceus (Bull.:Fr) Pers. Gartenbauwissenschaft, 60(5), 212-218). 미네랄은 Na, P, Mg 등의 순으로 많은데, 재배용의 원목이나 균상에 따라 회분조성도 영향을 받는다.The chemical composition of the roe deer mushroom is mainly composed of sugar and protein, and contains minerals but low fat content (Eisenhut, R., Fritz, D. and Tiefel, P. 1995. Investigations on nutritionally valuable constituents of Hericium erinaceus (Bull) .: Fr) Pers.Gartenbauwissenschaft, 60 (5), 212-218). There are many minerals in order of Na, P, Mg, etc., but ash composition is also affected by cultivation logs and fungi.
맛 성분으로는 유리 아미노산, 유리당(trehalose, manitol,arabinitol, glucose 등), 유기산(malic acid, fumaric acid, citric acid, α-ketoglutaric acid 등)이 존재한다. 기타 정미성분으로서 아데노신, 구아닌산, 구아노아데닌산 등의 핵산 성분이 존재하는데, 이들은 아미노산과의 상승작용에 의해 지미를 주는 것으로 알려지고 있다. Taste components include free amino acids, free sugars (trehalose, manitol, arabinitol, glucose, etc.) and organic acids (malic acid, fumaric acid, citric acid, α-ketoglutaric acid, etc.). Nucleic acid components such as adenosine, guanoic acid and guanoadenic acid exist as other taste components, and these are known to give Jimmy by synergy with amino acids.
비타민으로서는 B1, B2, 니아신(niacin)은 존재하나 비타민 A와 C는 검출되지 않는다. 또한, 광과 가열건조에 의해 비타민 D2로 변화하고 Ca의 흡수대사에 도움을 주어 골다공증의 예방 역할이 기대되는 에르고스테롤(ergosterol)이 보편적으로 존재한다. As vitamins, B1, B2 and niacin are present, but vitamins A and C are not detected. In addition, ergosterol (ergosterol), which is expected to play a role in preventing osteoporosis by changing to vitamin D2 by light and heat drying and helping to absorb metabolism of Ca, is commonly present.
그러나, 지금까지의 연구에 의하면 이러한 영양성분 외에도 노루궁뎅이버섯에는 약리활성 성분으로 헤라 세포(Hela cell) 증식저해물질, 신경성장인자(NGF) 합성유도 촉진 물질, 면역기능조절 성분(BRM 효과), 항종양 다당류, 렉틴(lectin), 식이섬유(β-glucan, chitin질, hetro 다당) 등이 있으며, 이들에 의해 대응하는 각종의 생리활성이 보고되고 있다[Mizuno, T. 1995. Yamabushitake, Hericium erinaceum: Bioactive substances and medicinal utilization. Food Reviews International, 11(1), 173-175]. However, studies to date have shown that in addition to these nutrients, snail mushrooms have pharmacologically active ingredients such as Hela cell proliferation inhibitors, nerve growth factor (NGF) -induced substances, immune function regulators (BRM effects), Anti-tumor polysaccharides, lectins, dietary fiber (β-glucan, chitin, hetro polysaccharides), and various biological activities have been reported by these [Mizuno, T. 1995. Yamabushitake, Hericium erinaceum : Bioactive substances and medicinal utilization. Food Reviews International, 11 (1), 173-175].
중국에서는 한방약으로 유명한데, 노루궁뎅이 자실체의 복합 다당류(hetero- polysaccharides)는 면역기능 조절에 기초한 항암작용(위암, 식암, 간장암, 피부암 등)을 갖는 것이 알려지고 있으며, 또한 노루궁뎅이버섯의 면역체계 강화에 의한 위, 십이지장 궤양 및 위암, 식도암에의 치료효과를 보고한 바 있고[Yang, Q.Y., and Jong, S.C. 1989. Medical mushrooms in China. Mush. Sci., 12(Part 1), 631-643], 항암 및 면역기능을 촉진시킴을 보고한 바 있다.[Ahn, D.K. 1992. Medicinal fungi in Korea. Kor. J. Mycol., 20,154-165 ].In China, it is famous as a herbal medicine. Hetero-polysaccharides of the fruiting beetle fruit body are known to have anticancer action (stomach cancer, food cancer, liver cancer, skin cancer, etc.) based on the regulation of immune function, and also the immune system of We have reported the effects of fortification on gastric, duodenal ulcer and gastric and esophageal cancer [Yang, QY, and Jong, SC 1989. Medical mushrooms in China. Mush. Sci., 12 (Part 1), 631-643], reported to promote anticancer and immune function. [Ahn, D.K. 1992. Medicinal fungi in Korea. Kor. J. Mycol., 20,154-165].
특히, 신경성장인자(NGF)의 합성유도 촉진활성을 나타내는 자실체 유래의 페놀 관련 화합물(hericenone C, D, E, Y-A-8-c)이나 균사체 유래 에리나신 (erinacine) A ∼ I 등에 의한 중추신경 재생과 알쯔하이머형 치매의 개선 효과를 밝혀 이들의 치료제로서의 이용가능성을 보고한 바 있다In particular, the central nervous system by phenol-related compounds derived from fruiting bodies (hericenone C, D, E, YA-8-c) exhibiting synthetic induction promoting activity of nerve growth factor (NGF) or erinacine A-I derived from mycelium It has been reported to improve the regeneration and Alzheimer's dementia, and to report its availability as a therapeutic agent.
상기와 같은 효능을 가진 노루궁뎅이 버섯의 재배기술은 1981년도 Liu에 의해 개발되어 고체 배양에 대한 인공재배가 가능해졌지만 고체 배양에 의한 자실체 생산에는 광선, 온도, 습도의 조절이 필요하며, 유효 성분의 추출 수율이 낮음으로 인해 고비용, 저생산성의 문제뿐만 아니라 품질 불균일성, 유통 중의 품질변화 등으로 인해 산업적 생산 체제로의 전환이 어려운 문제점이 있었다.The cultivation technology of roe deer mushroom with the above-mentioned efficacy was developed by Liu in 1981 to enable artificial cultivation of solid culture, but the production of fruiting bodies by solid culture requires control of light, temperature and humidity. Due to the low extraction yield, there was a problem that it is difficult to switch to the industrial production system due to high cost, low productivity, quality non-uniformity, quality change during distribution, and the like.
상기와 같은 문제점을 해결하기 위하여 1948년 미국에서 Humfeld가 아가리쿠 스 버섯에 대해 최초로 시도한 이래 지금까지 약 60여종의 식용 버섯에 대해 적용되고 검토되는 액체 배양방법을 이용하여 노루궁뎅이 버섯(Hericium erinaceus)의 액체 배양에 관한 Grigansky, Lomberh 등의 연구가 보고되고는 있으나, 이들의 연구 결과는 플라스크 수준에서 이루어진 것으로 균사체의 생산수율이 2.7~9.2g/L로 낮고, 배양기간이 10일 정도로 길어 균사체 생산의 최적화가 필요한 실정이다. Since the first attempt by Humfeld to agaricus mushroom in the United States in 1948 to solve the above problems, H. eryaceus mushroom (Hericium erinaceus) has been applied to the liquid culture method applied to and reviewed about 60 kinds of edible mushrooms. Grigansky, Lomberh et al. Have been reported on the culture of liquids, but the results of these studies were made at the flask level. The yield of the mycelium was low at 2.7-9.2g / L, and the culture period was 10 days. Optimization is needed.
본 발명은 상술한 문제점을 해결하기 위한 것으로서, 특히, 본 발명은 미강 또는 홍삼 추출물이 노루궁뎅이버섯의 균사체를 대량생산하는데 효과적임을 발견하고 노루궁뎅이버섯의 1차 배양액에 미강 또는 홍삼의 추출물을 첨가하여 2차 배양한 노루궁뎅이버섯의 기능성 균사체 생산 방법 및 상기 방법을 이용하여 생산된 노루궁뎅이버섯의 기능성 균사체를 통해 고체배양방식에서의 고비용, 저생산성의 문제와 품질 불균일성, 유통 중의 품질변화 등의 문제를 해결함으로서, 저렴한 비용으로 우수한 품질의 노루궁뎅이버섯의 기능성 균사체를 대량생산 할 수 있을 뿐만 아니라 기질로 사용된 미강 또는 홍삼 추출물에 의해 노인성 질병, 암, 면역체계 붕괴의 치료 및 뇌기능 활성 등의 효과를 가질 수 있도록 하는 미강 또는 홍삼을 기질로 한 노루궁뎅이버섯의 기능성 균사체 생산 방법 및 이를 이용하여 생산된 미강 또는 홍삼의 유효성분을 함유한 노루궁뎅이버섯의 기능성 균사체를 제공함에 목적이 있다.The present invention is to solve the above-mentioned problems, in particular, the present invention finds that the rice bran or red ginseng extract is effective in mass production of mycelia of roe deer fungus, and the extract of rice bran or red ginseng is added to the primary culture of The functional mycelium production method of the rotifera fungi cultured in the secondary culture and the functional mycelium of the roe deer fungus produced using the above method, such as high cost, low productivity and quality non-uniformity in the solid culture method, quality change in distribution, etc. By solving the problem, it is possible to mass-produce the functional mycelium of the high-quality locust fungus at low cost, as well as to treat senile disease, cancer, immune system breakdown and brain function activity by extracting rice bran or red ginseng used as a substrate. Roe deer beet based on rice bran or red ginseng to have the effect of To provide the functionality of the functional mycelium of mushroom mycelium production method and a Hericium erinaceus containing the effective components of the rice bran or red ginseng produced using this purpose.
상술한 목적을 달성하기 위한 본 발명의 특징은, 노루궁뎅이버섯의 균사체를 이용하여 1차 배양액을 제조하는 단계와, 상기 1차 배양단계에서 제조된 1차 배양 액에 미강 또는 홍삼의 추출물을 첨가한 후, 2차 배양하는 2차 배양단계를 포함하는 미강 또는 홍삼을 기질로 한 노루궁뎅이버섯의 기능성 균사체 생산 방법이다.Features of the present invention for achieving the above object, the step of preparing a primary culture using a mycelium of roe deer fungus, and adding the extract of rice bran or red ginseng to the primary culture solution prepared in the primary culture step After that, a method for producing a functional mycelium of roe deer fungus with a substrate of rice bran or red ginseng comprising a secondary culture step of secondary culture.
또한, 상술한 목적을 달성하기 위한 본 발명의 다른 특징은, 상기 특징의 생산 방법에 의하여 생산된 미강 또는 홍삼의 유효성분을 함유한 노루궁뎅이버섯의 기능성 균사체이다.In addition, another feature of the present invention for achieving the above object is a functional mycelium of roe deer fungus containing an active ingredient of rice bran or red ginseng produced by the production method of the above features.
상기 본 발명의 특징에 의한 1차 배양단계는, 포도당(glucose) 5%와, 이스트추출물(yeast extract)과 펩톤(peptone)을 1:1로 혼합한 혼합물 0.2%와, 인산칼륨무수물(KH2PO4)과 황산마그네슘(MgSO4)을 1:1로 혼합한 혼합물 0.2%을 혼합하여 배지를 조성하는 배지조성단계와, 상기 배지조성단계에서 조성된 배지에서 pH 4~6, 온도 20~30℃, 교반속도 100~200rpm, 작업용량(working volume) 50mL, 균사체 접종비 3~10%로 하여 종균을 배양하는 종균배양단계와, 상기 종균배양단계에서 배양된 종균을 생물반응기(Bio-reactor)에서 pH 5~6, 온도 20~30℃, 교반속도 100~200rpm, 통기속도 1~5vvm으로 4~8일간 배양하는 본 배양단계를 포함하는 구성으로 실시예를 구성할 수 있다. The primary culture step according to the characteristics of the present invention, glucose (glucose) 5%, yeast extract (yeast extract) and peptone (peptone) in a mixture of a mixture of 1: 1 and potassium phosphate anhydride (KH 2 PO 4 ) and 0.2% of a mixture of magnesium sulfate (MgSO 4 ) 1: 1 mixed to form a medium to form a medium, the pH 4 ~ 6, the temperature 20 ~ 30 in the medium formed in the medium composition step ℃, agitation speed 100 ~ 200rpm, working volume 50mL, mycelial seeding incubation step of cultivating spawn at 3 ~ 10%, and the spawn culture in the spawn culture step in the bio-reactor (Bio-reactor) pH 5 ~ 6, temperature 20 ~ 30 ℃, agitation speed 100 ~ 200rpm, aeration rate 1 to 5vvm can be configured to include an embodiment comprising a culturing step for 4 to 8 days incubation.
또한, 상기 본 발명의 특징에 의한 2차배양단계는, 미강 또는 홍삼의 열수추출물을 상기 본 배양단계에서 배양된 본 배양액에 건조량 기준으로 1~7% 첨가한 후, 100~200rpm, 20~30℃의 조건 하에서 2~3일간 추가 배양하는 구성으로 실시예를 구성할 수 있다.In addition, the secondary culture step according to the characteristics of the present invention, after adding 1 ~ 7% of the hot water extract of rice bran or red ginseng to the main culture cultured in the main culture step, based on the dry amount, 100 ~ 200rpm, 20 ~ 30 An example can be comprised by the structure which further cultures for 2-3 days under conditions of ° C.
상기 본 발명의 다른 특징에 의한 미강 또는 홍삼의 유효성분을 함유한 노루 궁뎅이버섯의 기능성 균사체는, 동결건조 한 후, 분쇄하여 분말화 시킨 상태로 노인성 질병, 암, 면역체계 붕괴의 치료용 조성물에 적용되는 실시예를 구성할 수 있다.The functional mycelium of roe deer fungus containing the active ingredient of rice bran or red ginseng according to another aspect of the present invention is lyophilized, and then pulverized and powdered in a composition for treatment of senile disease, cancer, and immune system collapse. It is possible to configure the applied embodiment.
상기 본 발명의 목적과 특징 및 장점은 첨부도면 및 다음의 상세한 설명을 참조함으로서 더욱 쉽게 이해될 수 있을 것이다.The objects, features and advantages of the present invention will be more readily understood by reference to the accompanying drawings and the following detailed description.
이하, 첨부된 도면을 참조하여 본 발명의 바람직한 실시예의 구성 및 그 작용 효과에 대해 상세히 설명하면 다음과 같다.Hereinafter, with reference to the accompanying drawings will be described in detail the configuration and effect of the preferred embodiment of the present invention.
도 1은 본 발명의 일실시예에 따른 미강 또는 홍삼을 기질로 한 노루궁뎅이버섯의 기능성 균사체 생산 방법의 흐름도로서, 본 발명의 미강 또는 홍삼을 기질로 한 노루궁뎅이버섯의 기능성 균사체의 생산방법을 개략적으로 나타내고 있다. 즉, 본 발명은 노루궁뎅이버섯의 균사체를 이용하여 1차 배양액을 제조하는 단계와, 상기 1차 배양단계에서 제조된 1차 배양액에 미강 또는 홍삼의 추출물을 첨가한 후, 2차 배양하는 2차 배양단계를 포함하는 것으로서,1 is a flow chart of a method for producing functional mycelium of roe deer fungus mushrooms based on rice bran or red ginseng according to an embodiment of the present invention, the production method of functional mycelium of roe deer fungus mushrooms based on rice bran or red ginseng of the present invention It is shown schematically. That is, the present invention comprises the steps of preparing a primary culture using a mycelium of roe deer fungus, and after adding the extract of rice bran or red ginseng to the primary culture prepared in the primary culture step, secondary culture As comprising a culturing step,
상기 1차 배양단계는, 배지조성단계와, 종균배양단계와, 본 배양단계를 포함하여 제조된다.The primary culture step is prepared, including the medium composition step, spawn culture step, and the present culture step.
상기 배지조성단계는, 기능성 균사체를 배양하기 위한 최적의 배지를 조성하는 단계로서, 포도당(glucose) 5%와, 이스트추출물(yeast extract)과 펩톤(peptone)을 1:1로 혼합한 혼합물 0.2%와, 인산칼륨무수물(KH2PO4)과 황산마그네슘(MgSO4)을 1:1로 혼합한 혼합물 0.2%을 혼합하여 배지를 조성하게 되며,The medium composition step is to create an optimal medium for cultivating functional mycelia, glucose (5%), yeast extract (yeast extract) and peptone (peptone) in a 1: 1 mixture of 0.2% And, a medium is prepared by mixing 0.2% of a mixture of potassium phosphate anhydride (KH 2 PO 4 ) and magnesium sulfate (MgSO 4 ) in a 1: 1 ratio,
상기 종균배양단계는, 상기 배지조성단계에서 조성된 배지에서 종균을 배양하는 단계로서, pH 4~6, 온도 20~30℃, 교반속도 100~200rpm, 작업용량(working volume) 50mL, 균사체 접종비 3~7%로 하여 종균을 배양하게 되고, The seed culture step is a step of culturing the seed in the medium prepared in the medium composition step, pH 4 ~ 6, temperature 20 ~ 30 ℃, stirring speed 100 ~ 200rpm, working volume 50mL, mycelia inoculation ratio 3 The seed is incubated at ~ 7%,
상기 본 배양단계는, 상기 종균배양단계에서 배양된 종균을 본 배양하여 기능성 균사체를 생산하는 것으로서, 생물반응기(Bio-reactor)에서 pH 5~6, 온도 25~30℃, 교반속도 100~200rpm, 통기속도 1~5vvm으로 4~8일간 배양하게 된다. The culturing step is to produce functional mycelium by culturing the seed culture cultivated in the seed culture step, pH 5-6 in a bio-reactor, temperature 25-30 ° C., agitation speed 100-200 rpm, Incubate 4-8 days at aeration rate 1-5vvm.
상기 2차배양단계는, 상기의 배양과정을 거쳐 조성된 1차배양액에 미강 또는 홍삼 등의 추출물을 첨가하여 추가 배양하는 것으로서, 미강 또는 홍삼의 열수추출물을 상기 본 배양단계에서 배양된 본 배양액에 건조량 기준으로 1~7% 첨가한 후, 100~200rpm, 20~30℃의 조건 하에서 2~3일간 추가 배양하고, 원심분리하여 균사체를 생산하게 된다.The secondary culture step is to further culture by adding an extract, such as rice bran or red ginseng to the primary culture liquid prepared through the above culturing process, the hot water extract of rice bran or red ginseng to the main culture cultured in the main culture step After the addition of 1 to 7% on a dry basis, 100 to 200 rpm, 20 to 30 ℃ further incubated for 2 to 3 days, and centrifuged to produce a mycelium.
상기의 일실시예에 따른 배지조성단계의 최적 배지조성, 미강성분의 투입시기별 균사체 생성량 비교, 상기 비교실험을 위한 종균배양 시의 최적배양 조건 등을 하기의 실험예 1을 통해 설명 및 증명하면 다음과 같다.If the optimum medium composition of the medium composition step according to the embodiment, the comparison of the mycelial production amount according to the input time of the rice bran component, the optimum culture conditions during the spawn culture for the comparison experiment, etc. As follows.
실험예 1Experimental Example 1
4 요소 혼합물의 구성성분(factor mixture component, 물, 탄소원(C-source), 질소원(N-source), 미네랄(Mineral))과 6-단계의 양(level amount, 0, 1,1/2,1/3,1/4,1/6)의 엠에이(MA, mixture amount)를 이용한 심플랙스 중심설계(Simplex-centroid design)의 혼합물 실험법을 하기 표 1과 같이 수행하였으며, Factor mixture component (water, C-source, N-source, mineral) and 6-level amount (0, 1, 1/2, 1 / 3,1 / 4,1 / 6) Mixture experiment of the Simplex-centroid design using a mixture amount (MA, MA) was performed as shown in Table 1 below.
표 1. 엠에이(MA, mixture amount)를 이용한 심플랙스 중심설계(Simplex- centroid design)의 혼합물 실험조건Table 1. Mixture test conditions of Simplex-centroid design using mixture amount (MA)
해당 최적 배지 조성을 가진 배지에 접종비 5%, 온도 10~30℃, 교반속도 100rpm으로 9일간 배양한 결과를 바탕으로 최적 배지 조성의 혼합비를 평가하여 최적 배지 조성 조건인 포도당(glucose) 5%와, 이스트추출물(yeast extract)과 펩톤(peptone)을 1:1로 혼합한 혼합물 0.2%와, 인산칼륨무수물(KH2PO4)과 황산마그네슘(MgSO4)을 1:1로 혼합한 혼합물 0.2%로 설정하였다.Based on the result of incubation for 9 days at the inoculation ratio of 5%, the temperature of 10 ~ 30 ℃, agitation speed of 100rpm in the medium having the optimum medium composition, the mixture ratio of the optimal medium composition was evaluated by 5% glucose (glucose), 0.2% mixture of yeast extract and peptone in 1: 1, 0.2% mixture of potassium phosphate anhydride (KH 2 PO 4 ) and magnesium sulfate (MgSO 4 ) in 1: 1 Set.
상기와 같이 최적 배지의 조건을 설정하기 위하여 9일간 배양한 배양액을 다시 배양온도 25~35℃, 통기 속도 0.5~2.0vvm, 교반속도 100~300rpm으로 약 8일간, 표 2와 같은 조건하에서 1차 액체 배양을 수행하여 최적 배양조건을 구한 후, pH 5~6, 배양온도 25~30℃, 교반속도 100~200rpm으로 약 4~8일간 종균배양하였다. In order to set the conditions of the optimum medium as described above, the culture broth was incubated for 9 days at 25-35 ° C., aeration rate 0.5-2.0vvm, and agitation speed 100-300 rpm for about 8 days, under the conditions shown in Table 2 below. After optimizing the culture conditions by performing liquid culture, the seed was incubated for about 4 to 8 days at pH 5 ~ 6, incubation temperature 25 ~ 30 ℃, stirring speed 100 ~ 200rpm.
표 2. 배양조건의 중심요소를 설정하기 위한 변수와 그들의 단계Table 2. Variables and their steps to establish central elements of culture conditions
상기 최적 배지 및 배양조건하에 1차 액체 본 배양을 수행하고 균사생육이 충분히 이루어진 5일 이후에 미강성분을 투입하여 2단계 배양을 실시하여 균사체의 생산량을 증대시켰다.The primary liquid main culture was carried out under the optimum medium and culture conditions, and 5 days after the mycelial growth was sufficiently performed, the rice bran component was added to carry out the two-step culture to increase the production of the mycelia.
상기에 첨가되는 미강 추출물의 첨가량은 건조량 기준으로 1~7%(바람직하게는 3∼6%) 첨가하며, 20 ∼ 50 ℃(바람직하게는 20∼30℃)에서 정치 또는 진탕배양하여 2단계 배양을 실시하는 것이 바람직하다. 전체 8일간의 액체 배양 기간 중 미강 추출물의 투입 시기별로 균사체의 생육을 조사한 결과를 표 3에 나타내었다.The amount of the rice bran extract added to the above is 1 to 7% (preferably 3 to 6%) on the basis of the dry amount, and the two-step culture by standing or shaking culture at 20 to 50 ℃ (preferably 20 to 30 ℃) It is preferable to carry out. Table 3 shows the results of the growth of the mycelia by the input time of the rice bran extract during the whole 8 days of liquid culture.
표 3. 균사체 생성량의 비교Table 3. Comparison of Mycelial Production
상기의 표 3에서 알 수 있듯이 배양 0일차부터 투입시는 기존 마늘 등을 이용한 균사체 배양 실험의 결과와 같이 균사체의 생육 자체가 저해되는 경향을 보였으나, 1일차 이상 경과 한 후에 미강 추출물을 투입시에는 초기에 다소 균사체 생육이 저하되는 듯 하다가 투입시기가 늦을수록 그 생성량이 급속이 증가하여 배양 4-5일 이후 첨가함으로써 기존의 일반적인 액체 배양 방법대비 월등히 많은 균사체의 생성이 가능하였다.As can be seen in Table 3 above, when starting from day 0 of culture, the growth of mycelium itself tended to be inhibited as in the results of mycelial culture experiments using garlic, but when the rice bran extract was added after 1 day or more, In the early stage, the growth of mycelium seemed to be somewhat decreased, but as the input time was delayed, the production amount increased rapidly, and after 4-5 days of incubation, the mycelium growth was much higher than that of the conventional liquid culture method.
구체적으로 살펴보면, 이 방법으로 배양초기 미강이나 홍삼 추출물의 첨가시는 균사체 생성량이 약 1.5g/L에 불과하였으나 1차 배양 4-5일 후 첨가시는 20, 75 및 300 L 발효기에서 16.65~17.89g/L 까지 얻을 수 있으며, 이는 통상적인 액체배양의 4.25~10.77g/L에 비해서도 160~300% 이상 향상된 것이다.In detail, the mycelial production was only about 1.5 g / L when the initial cultivation of rice bran or red ginseng extract was added with this method, but 16.65 ~ 17.89 in 20, 75, and 300 L fermenters after 4-5 days of primary culture. Up to g / L can be obtained, which is more than 160-300% improvement over 4.25-10.77 g / L of conventional liquid culture.
이외에도 본 발명인 미강 또는 홍삼을 기질로 한 노루궁뎅이버섯의 기능성 균사체 생산 방법 및 이를 이용하여 생산된 미강 또는 홍삼의 유효성분을 함유한 노루궁뎅이버섯의 기능성 균사체는 다양하게 변형실시될 수 있는 것으로, 본 발명의 목적범위를 일탈하지 않는 한, 변형되는 실시예들은 모두 본 발명의 권리범위에 포함되어 해석되어야 한다.In addition to the functional mycelium production method of the present invention of the rice bran or red ginseng as a substrate, and the functional mycelium of the roe deer fungus containing the active ingredient of the rice bran or red ginseng produced by the present invention can be variously modified, Unless departing from the scope of the invention, all modified embodiments should be construed as being included in the scope of the invention.
이상의 본 발명에 의하면, 고체배양방식에서의 고비용, 저생산성의 문제와 품질 불균일성, 유통 중의 품질변화 등의 문제를 해결함으로서, 저렴한 비용으로 우수한 품질의 노루궁뎅이버섯의 기능성 균사체를 대량생산 할 수 있을 뿐만 아니라 기질로 사용된 미강 또는 홍삼 추출물에 의해 노인성 질병, 암, 면역체계 붕괴의 치료 및 뇌기능 활성 등의 효과를 가질 수 있게 되는 등의 이점을 얻을 수 있게 된다.According to the present invention, by solving the problems of high cost, low productivity and quality non-uniformity, quality change during distribution in the solid culture method, it is possible to mass-produce functional mycelium of roe deer fungus of high quality at low cost In addition, by using the rice bran or red ginseng extract used as a substrate can be obtained such as the effects of the treatment of senile diseases, cancer, immune system breakdown and brain function activity.
Claims (5)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060115795A KR100826446B1 (en) | 2006-11-22 | 2006-11-22 | Hericium erinaceus mycelium comprising rice bran and ginseng steamed red and it's cultivation method |
JP2009538321A JP2010510305A (en) | 2006-11-22 | 2007-11-20 | Method for producing functional mycelium of yamabushitake using rice bran or red ginseng as substrate, and functional mycelium of yamabushitake containing active ingredients of rice bran or red ginseng produced using the same |
PCT/KR2007/005823 WO2008062983A1 (en) | 2006-11-22 | 2007-11-20 | Hericium erinaceus mycelium comprising rice bran and ginseng steamed red and cultivation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060115795A KR100826446B1 (en) | 2006-11-22 | 2006-11-22 | Hericium erinaceus mycelium comprising rice bran and ginseng steamed red and it's cultivation method |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100826446B1 true KR100826446B1 (en) | 2008-04-29 |
Family
ID=39429887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060115795A KR100826446B1 (en) | 2006-11-22 | 2006-11-22 | Hericium erinaceus mycelium comprising rice bran and ginseng steamed red and it's cultivation method |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2010510305A (en) |
KR (1) | KR100826446B1 (en) |
WO (1) | WO2008062983A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101235205B1 (en) | 2010-05-26 | 2013-02-20 | 정재현 | A liquid culture method of Hericium erinaceum using Artemisia swayomogi and Hericium erinaceum culture material of culturing thereof |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102224922B (en) * | 2011-04-20 | 2013-01-30 | 陈心智 | Health food with functions of immunoregulation and gastroiontestinal function improvement |
CN103755417B (en) * | 2013-12-27 | 2015-09-30 | 内蒙古科技大学 | A kind of production method of Hericium erinaceus (Bull. Ex Fr.) Pers. Rich in selenium mycelium liquid fermentation |
CN103947460B (en) * | 2014-05-13 | 2015-09-23 | 四川省农业科学院土壤肥料研究所 | A kind of field production method of Stropharia rugoso-annulata |
CN104146238B (en) * | 2014-07-11 | 2015-08-05 | 吉林大学 | A kind of have the health food strengthening body immunity function |
CN104303837B (en) * | 2014-10-13 | 2017-01-11 | 上海市农业科学院 | Secondary fungus culture method for mushroom factory production |
US20210069170A1 (en) | 2016-07-23 | 2021-03-11 | Paul Edward Stamets | Tryptamine compositions for enhancing neurite outgrowth |
US20180021326A1 (en) | 2016-07-23 | 2018-01-25 | Paul Edward Stamets | Compositions and methods for enhancing neuroregeneration and cognition by combining mushroom extracts containing active ingredients psilocin or psilocybin with erinacines or hericenones enhanced with niacin |
US11701348B1 (en) | 2016-07-23 | 2023-07-18 | Turtle Bear Holdings, Llc | Psilocybin compositions |
CN107788506A (en) * | 2017-10-18 | 2018-03-13 | 合肥河川生物医药科技有限公司 | Selenium-enriched hericium erinaceus powder and its production method and its purposes as selenium fortification agent |
CN109169899A (en) * | 2018-07-17 | 2019-01-11 | 上海应用技术大学 | A kind of preparation method of the shield stomach acidified milk containing Hericium erinaceus beta glucan |
CN109937799B (en) * | 2019-03-13 | 2021-08-17 | 广西壮仁堂生物科技有限公司 | Cordyceps sinensis mycelium with beautifying function |
CN109937800B (en) * | 2019-03-13 | 2021-08-17 | 广西壮仁堂生物科技有限公司 | Cordyceps sinensis mycelium with kidney nourishing and protecting functions and preparation method thereof |
US11660305B2 (en) | 2019-11-19 | 2023-05-30 | Turtle Bear Holdings, Llc | Tryptamine compositions for enhancing neurite outgrowth |
CN113349368A (en) * | 2021-05-28 | 2021-09-07 | 长春中医药大学 | Preparation process and application of hericium erinaceus-ginseng fermentation mycoplasm enzyme oral liquid |
CN113287707A (en) * | 2021-05-28 | 2021-08-24 | 长春中医药大学 | Ginseng and hericium erinaceus bidirectional solid fermentation mycoplasm solid beverage and preparation method thereof |
CN118388677B (en) * | 2024-06-26 | 2024-10-11 | 广东嘉士利食品集团有限公司 | Extraction method and application of hericium erinaceus polysaccharide |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000021764A (en) * | 1998-09-30 | 2000-04-25 | 임양빈 | Artificial cultivation of hericium erinaceus |
KR20020072878A (en) * | 2001-03-13 | 2002-09-19 | 에이치엔엠바이오(주) | Method for solid culturing of hyphostroma and carpophore of hericicum erinaceus using a medicinal plant and food to help health including abstract of hyphostroma and carpophore |
KR20050079789A (en) * | 2004-02-06 | 2005-08-11 | 에이치엔엠바이오(주) | Anti-cancer composition containing mushroom cultivated in artemisa iwaomogi |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100523263B1 (en) * | 2003-07-24 | 2005-10-24 | 주식회사 코시스바이오 | Media containing mushroom and mushroom culturing method using same |
-
2006
- 2006-11-22 KR KR1020060115795A patent/KR100826446B1/en active IP Right Grant
-
2007
- 2007-11-20 JP JP2009538321A patent/JP2010510305A/en active Pending
- 2007-11-20 WO PCT/KR2007/005823 patent/WO2008062983A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000021764A (en) * | 1998-09-30 | 2000-04-25 | 임양빈 | Artificial cultivation of hericium erinaceus |
KR20020072878A (en) * | 2001-03-13 | 2002-09-19 | 에이치엔엠바이오(주) | Method for solid culturing of hyphostroma and carpophore of hericicum erinaceus using a medicinal plant and food to help health including abstract of hyphostroma and carpophore |
KR20050079789A (en) * | 2004-02-06 | 2005-08-11 | 에이치엔엠바이오(주) | Anti-cancer composition containing mushroom cultivated in artemisa iwaomogi |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101235205B1 (en) | 2010-05-26 | 2013-02-20 | 정재현 | A liquid culture method of Hericium erinaceum using Artemisia swayomogi and Hericium erinaceum culture material of culturing thereof |
Also Published As
Publication number | Publication date |
---|---|
JP2010510305A (en) | 2010-04-02 |
WO2008062983A1 (en) | 2008-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100826446B1 (en) | Hericium erinaceus mycelium comprising rice bran and ginseng steamed red and it's cultivation method | |
KR101629793B1 (en) | A medium for production of morchella esculenta | |
CN102351605B (en) | Culture method for liquid fermentation of rare edible-medicinal fungus Sparassis crispa and special medium thereof | |
CN102037856B (en) | Simple cordyceps militaris strain rejuvenation method | |
CN102391034A (en) | Formula and preparation method of Pleurotus eryngii liquid strain culture medium | |
Zhou | Cultivation of Ganoderma lucidum | |
KR20150140145A (en) | A artificial culture method for mass producing mycelium of morchella esculenta | |
CN103011935A (en) | Boletus mother culture medium and preparation method thereof | |
KR101012405B1 (en) | The process of a mushroom mycelium fermented and functional food using the same | |
KR20040047730A (en) | Composition for the culturing of Phellinus linteus mycelium | |
KR100523263B1 (en) | Media containing mushroom and mushroom culturing method using same | |
Agarwal et al. | Yield, biological efficiency and nutritional value of Pleurotus sajor-caju cultivated on floral and agro-waste | |
CN103371044A (en) | Selenium-enriched cordyceps flower production method | |
KR101223464B1 (en) | Method of culturing mushroom using hippophae rhamniodes and culture material of culturing thereof | |
KR100204984B1 (en) | The method of culturing phellinus linteus | |
CN103688748B (en) | Epimedium cordyceps militaris cultivation and product processing method | |
KR102333307B1 (en) | Methods of artificial cultivation of Clavicorona sp. | |
KR20120097190A (en) | Production method of the clavicoron pyxidata | |
KR100225050B1 (en) | The phelinus linteus composition | |
JP2003061644A (en) | Method for efficiently culturing ganoderma boninense pat. using algae | |
CN114907983B (en) | Pleurotus ostreatus mycelium liquid culture medium and fermentation method of Pleurotus ostreatus mycelium | |
CN108102927A (en) | A kind of fluid nutrient medium of Termitomyces albuminosus with black skin parent species and preparation method thereof | |
KR20010004813A (en) | The use of soybean waste for the cultivation of mushroms | |
KR101190094B1 (en) | Production method of the cauliflower mushroom hypha using grain medium | |
KR20120122263A (en) | Manufacturing Method of Fermented Materials for liver function improvement using Acanthopanax sp. extracts and Functional food of Thereof Manufacturing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
N231 | Notification of change of applicant | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
AMND | Amendment | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130315 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140228 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20150227 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20180226 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20190225 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20200225 Year of fee payment: 13 |